Objective: To measure the correlations between habitual intakes of individual n-6 and n-3 polyunsaturated fatty acids (PUFA) and their percentages in total plasma fatty acids in a population of adult men and women. Subjects/Methods: Two hundred and seventy-six men and 257 women aged 45-60 (men) or 35-60 (women) at baseline, volunteers of the French SU.VI.MAX cohort. Fifteen 24-h record questionnaires were used to estimate the habitual intake of energy, total fat and linoleic, a-linolenic acid, arachidonic, eicosapentaenoic (EPA), n-3 docosapentaenoic (DPA) and docosahexaenoic (DHA) acids. Fatty acid composition of fasting plasma total lipids has been determined at baseline. Results: Dietary intakes of linoleic acid, arachidonic acid, EPA and DHA were weakly but significantly correlated (0.16oro0.28, Po0.01) with their respective percentages in plasma total fatty acids in both men and women. No correlation was observed between the plasma levels of a-linolenic acid and its dietary intake, and between the plasma levels of arachidonic acid and longchain n-3 PUFA and the intakes of their 18-carbon precursors, linoleic and a-linolenic acid, respectively. Conclusions: The percentages of linoleic acid, arachidonic acid, EPA and DHA in plasma total fatty acids, but not that of alinolenic acid, are acceptable markers of their habitual levels of intake. The plasma levels of long-chain n-6 and n-3 PUFA are not influenced by the intake levels of their precursors, linoleic and a-linolenic acids.
Introduction
Essential fatty acids (EFA) are nutrients of primary importance for health, and many research works in the last decades have shown the role of an adequate intake of n-6 and n-3 polyunsaturated fatty acids (PUFA) in the prevention of several diseases, in particular of cardiovascular diseases (Carroll and Roth, 2002) . Therefore, the estimation of PUFA intake in populations is a major goal in nutritional epidemiology. As the conversion of linoleic and a-linolenic acids into long-chain PUFA occurs in humans with only a low yield (Burdge, 2004) , the intake of even small amounts of long-chain n-6 and n-3 PUFA can contribute significantly to the EFA status (Simopoulos, 2002) . Therefore, the evaluation of the adequacy of EFA intakes in a population needs to estimate the intakes of both precursor fatty acids (linoleic and a-linolenic acids) and main long-chain PUFA of the n-6 and n-3 series, that is, arachidonic acid (n-6 series) and eicosapentaenoic (EPA), docosapentaenoic (DPA) and docosahexaenoic (DHA) (n-3 series). The estimation of the individual PUFA intakes requires the use of a sufficiently detailed dietary questionnaire. An alternative is the use of biomarkers: blood or tissue PUFA levels. Plasma, erythrocytes or adipose tissue fatty acids have often been used in this purpose. In a previous study (Astorg et al., 2004) , we have estimated the intakes of individual n-6 and n-3 PUFA in participants of the SU.VI.MAX cohort, the food consumption in whom has been measured by repeated 24-h records. In the present study, we have assessed the relationships between the intakes of the main dietary PUFA of the n-6 series (linoleic and arachidonic acids) and of the n-3 series (a-linolenic acid, EPA, DPA and DHA) and their levels in plasma total lipids in a subsample of this cohort.
Methods

Population sample
The SU.VI.MAX study is a randomized, double-blind, placebo-controlled primary prevention trial designed to test the effects of daily supplementation with a mixture of vitamin C, vitamin E, b-carotene, zinc and selenium on the incidence of ischaemic heart diseases and of cancers in a population of adult men and women (Hercberg et al., 1998 . Another objective of the study was to evaluate food consumption in a national sample of middle-aged subjects from all over France. The cohort consisted of 13 017 subjects (5141 men and 7876 women) who were included in 1994-1995 with a planned follow-up of 8 years (Hercberg et al., 1998 . Men were aged 45-60 and women 35-60 at enrolment. Details on study design, recruitment and baseline characteristics of the subjects have been reported previously (Hercberg et al., 1998) . All subjects gave their informed written consent to the study. The study was approved by ad hoc ethical committees. Fasting blood samples were taken up at inclusion from all subjects, immediately centrifuged and plasma samples were stored in liquid nitrogen until use. The fatty acid composition of plasma total lipids has been determined on 1332 subjects selected to be included in a nested case-control study. As the blood samples were taken up at baseline, the assignment of the subjects to an intervention group or the later onset of disease in some subjects is unlikely to have influenced the relation between plasma fatty acid composition and habitual fatty acid intake.
Dietary assessment
At inclusion and every 2 months until the end of the study, subjects were asked to complete a 24-h dietary record questionnaire, which included a large choice of foods and drinks (about 900 items) for each of the three meals (breakfast, lunch and dinner) and of four other food intake occurrences, with indication of the portion size consumed. The questionnaire also included questions on the type of oil or fat used for seasoning or cooking. Other details on 24-h dietary records have been published previously (Hercberg et al., 1998; Astorg et al., 2004) .
Food composition table
The contents of foods in energy, total fat, linoleic acid, alinolenic acid, arachidonic acid and the long-chain n-3 PUFA EPA, DPA and DHA, included in the SU.VI.MAX food composition table (Arnault et al., 2006) , have been compiled from the French food composition table (Favier et al., 1995; Ireland et al., 2002) Determination of the fatty acid composition of plasma total lipids Lipids were extracted from 150 ml aliquots of plasma with hexane/isopropanol (3:2, v:v), saponified with NaOH in dry methanol at 1001C, and the fatty acids were methylated with boron trifluoride (14%) in methanol. The fatty acid methyl esters were quantified by gas-liquid chromatography using a capillary column (AT-WAX polar 30 m length, 0.25 mm i.d., film thickness 0.25 mm), and hydrogen as carrier gas. Peak identification was made by comparison of their elution times with that of a mixture of commercial standards. The results were expressed as percentages of the total area of all fatty acid peaks, which ranged from 14:0 (myristic acid) to 22:6n-3 (DHA).
Statistical analyses
As correlation studies need a good estimation of individual intakes, we have calculated the number of records necessary to estimate correctly the intake of PUFA, using a method described previously (Nelson et al., 1989) . This number is given by n ¼ are the intra-and inter-individual variances, and r the inobservable correlation between the observed and true mean nutrient intakes by a given subject. We fixed r at the value of 0.9, which allows 75% of the subjects belonging to the extreme quintiles to be classified correctly (Nelson et al., 1989) . In a previous work, 10 dietary records or less have been found to be sufficient to estimate the individual intakes of energy, macronutrients, total fat and main fatty acid classes with a good accuracy (Mennen et al., 2002) . We have found here that 15 records completed over a period of 3 years were necessary to estimate the intakes of linoleic acid, a-linolenic acid, arachidonic acid, EPA, DPA and DHA. We have consequently restricted the study sample to the subjects having complete dietary data from at least 15 24-h records among those who had their plasma fatty acid composition determined, that is to 533 subjects: 276 men and 257 women. It is clear that the selection operated was not at random, and that the final sample of 533 subjects is representative neither of the 1332 subjects with blood fatty acid profiles, nor of the whole cohort. These 533 subjects, who were the most compliant to the study, are likely to be among the most health-conscious and nutritionally aware of the volunteers. However, this selection is not likely to have modified the nature and the intensity of the relations between dietary PUFA and plasma PUFA levels, which was the goal of this study.
Statistical analyses were performed using SAS software (SAS Institute, Cary, NC, USA). Comparisons between men and women were performed using the Student's t-test. Logtransformed data were used for variables with a skewed distribution. Relationships between variables were assessed using partial Spearman's rank correlation coefficients.
Results
Expressed as percent of energy intake, total fat, linoleic and a-linolenic acid intakes were significantly higher in women than in men, however, the intakes of individual long-chain n-6 and n-3 PUFA were similar in both sexes (Table 1) . Our sample is characterized by a high linoleic acid intake (about 5% of total energy intake) and a low a-linolenic acid intake (about 0.4% of energy) and a high linoleic/a-linolenic ratio (about 13). These values of lipid and PUFA intakes are very similar to those found in a larger sample from the same cohort (Astorg et al., 2004) .
The correlations between plasma fatty acid percentages and lipid and fatty acid intakes expressed either in g or mg/day or as % of total energy intake have been calculated. As the two modes of expression gave similar results, only the correlations with intakes expressed as % of energy intake are presented in Table 2 . The percentages of linoleic acid, arachidonic acid, EPA and DHA in plasma lipids were significantly, although weakly, correlated with their respective dietary intakes (0.16prp0.29). Higher values of the correlation coefficients were found for EPA and DHA. The dietary intakes of a-linolenic acid and DPA were not correlated at all with their respective percentages in plasma lipids. DPA intake was significantly correlated with the plasma levels of EPA and DHA, both of which are thus markers of long-chain n-3 PUFA intake. No correlation was observed between the plasma levels of arachidonic acid, EPA, DPA and DHA and the intakes of their 18-carbon precursors, linoleic and a-linolenic acid, respectively. Linoleic acid intake was negatively correlated with the plasma level of a very minor fatty acid (ca. 0.15% of fatty acids): 20:3n-9, a bioconversion product of oleic acid (correlations: r ¼ À0.29, Po0.0001, in men; r ¼ À0.20, Po0.001, in women). In men, but not in women, the intakes of EPA, DPA and DHA were negatively correlated with the plasma levels of 20:2n-6, 20:3n-6 and 22:4n-6, and the intake of arachidonic acid was negatively correlated to the plasma levels of 20:2n-6 and 20:3n-6 ( Table 2 ). The intakes of fish and seafood in the population sample were (mean7s.d.): lean fish, 23.0720.0 g/day in men and 19.1716.8 g/day in women; fatty fish, 16.5716.0 g/day in men and 13.2713.0 g/day in women; seafood, 12.8716.0 g/day in men and 8.6710.4 g/day in women; total fish and seafood, 52.3733.0 g/day in men and 41.0725.5 g/day in women. In both sexes, the plasma levels of EPA and DHA were correlated with the intakes of fish, fish and seafood and fatty fish, but not or only very weakly with the intakes of lean fish or seafood alone (Table 3 ). The plasma level of DPA was not correlated with the intakes of any of the fish and seafood items (Table 3) .
Discussion
In this study, we have found that the plasma levels of linoleic acid, arachidonic acid, EPA and DHA, but not of a-linolenic acid, were significantly correlated with their respective habitual intakes measured by repeated 24-h records. No Table 1 Dietary intakes and plasma levels of n-6 and n-3 PUFA in men and women Plasma n-6 and n-3 PUFA as biomarkers of their intake P Astorg et al correlation was observed between the intake of the n-6 or n-3 precursors, linoleic or a-linolenic acids, and the plasma levels of their long-chain derivatives, arachidonic acid, or EPA, DPA and DHA, respectively.
Since n-6 or n-3 PUFA are not biosynthesized de novo by the organism, blood or tissue PUFA levels are expected to vary with their intake levels. The blood or tissue lipids in which fatty acid biomarkers can be measured differ in their All fish species not classified as fatty fish (containing less than 0.5 g of long-chain n-3 PUFA/100 g). Anchovy, sea bass, carp, dogfish, eel, halibut, herring, mackerel, mullet, salmon, sardine, trout, fresh tuna (containing more than 0.5 g of long-chain n-3 PUFA/ 100 g). d Molluscs, crustaceans and sea urchins.
delay of response to dietary changes: plasma fatty acid composition reflects the last 1-2 weeks of diet, red blood cell fatty acids reflect the last 1-2 months and adipose tissue fatty acids, the previous years (Katan et al., 1997; Arab, 2003) . In addition, specificities in the fatty acid composition of blood or tissue lipid classes make that a given class can be a good biomarker of some PUFA, but not of others. In particular, a-linolenic acid intake is correlated with its percentage in plasma cholesteryl esters (Ma et al., 1995b; Katan et al., 1997; Amiano et al., 2001; Iwamoto et al., 2002) , but not with the small amount present in plasma or erythrocyte phospholipids (Ma et al., 1995b; Kobayashi et al., 2001) . However, the intake of long-chain n-3 PUFA is mirrored in all blood lipid fractions, especially plasma cholesteryl esters and plasma or red blood cell phospholipids (Ma et al., 1995b; Katan et al., 1997; Kobayashi et al., 2001) . The use of fatty acid percentages in total plasma lipids has two main advantages:
(1) it cumulates the biomarker specificities of plasma cholesterol ester and phospholipid, that is could be a biomarker of intake of both precursor (linoleic and alinolenic acids) and long-chain PUFA (arachidonic acid, EPA and DHA); (2) it is technically simpler and faster than the methods using a defined lipid class, and thus more easily applicable to large population samples. The mean n-6 and n-3 PUFA percentages in plasma lipids are influenced by the mean intake of the population studied. Thus, the plasma level of a-linolenic acid in our sample (0.5-0.6%) is lower than that found in Japan (0.8-0.9%) (Kuriki et al., 2002 (Kuriki et al., , 2003 or in United Kingdom (1.3-1.4%) (Rosell et al., 2005) , reflecting the low a-linolenic acid intake of the French population (Astorg et al., 2004) . At variance, the plasma linoleic acid levels reach values (30-35% of fatty acids) comparable to those found in United Kingdom (Rosell et al., 2005) , Norway (Andersen et al., 1999) , Japan (Kuriki et al., 2002 (Kuriki et al., , 2003 or Costa-Rica (Kuriki et al., 2003; Baylin et al., 2005) , reflecting the high intakes of linoleic acid in most world countries (4-6% of energy) (Simopoulos, 2002) . Plasma levels of long-chain n-3 PUFA in our sample are much higher than in populations eating no or little fish (Baylin et al., 2005; Rosell et al., 2005) , similar to those found in Norway (Andersen et al., 1999) , and lower than those found in countries with a high fish consumption such as Spain (Amiano et al., 2001) or Japan (Kuriki et al., 2002 (Kuriki et al., , 2003 . In Europe, the French rank among the higher fish and seafood consumers, after the Spanish and the Scandinavians (Welch et al., 2002) . In our study, the plasma levels of EPA and DHA are correlated with the intakes of fatty fish, as well as with the intakes of total fish and of total fish and seafood, but not with the intakes of lean fish or of seafood. This clearly results of the fact that fatty fish is the main contributor to the intake of EPA (44.1% of the intake) and of DHA (41.1% ) (Astorg et al., 2004) . Fatty fish intake was found to vary widely across quintiles of intakes of long-chain n-3 fatty acids: from 1.7 (in men) or 0.9 g/day (in women) in the first quintile to 36.3 or 31.1 g/day, respectively, in the fifth quintile (Astorg et al., 2004) . Thus, the intake of fatty fish, the main source of variation of EPA and DHA intakes, is also a main source of variation of their plasma levels. On the whole, fish and seafood contributes to 72.0% of the intake of EPA and 64.7% of the intake of DHA, but only to 32.4% of the intake of DPA, which is mainly brought by meat, poultry and eggs (Astorg et al., 2004) . This explains why the plasma level of DPA showed no correlation with fish and seafood intake.
Previous studies have assessed the relationships between the plasma levels of individual PUFA and their intakes measured a diet history (Amiano et al., 2001 ), a 7-day weighed dietary record during the week preceding blood sampling (Kuriki et al., 2002 (Kuriki et al., , 2003 , or a food-frequency questionnaire (Andersen et al., 1999) . In these studies, the dietary intakes of long-chain n-3 fatty acids EPA and DHA were significantly correlated with their plasma levels (r ¼ 0.3-0.8), but the correlations were stronger in studies where the intakes are measured shortly after or before blood sampling (Andersen et al., 1999) , especially in those using weighed dietary records (r ¼ 0.6-0.8) (Kuriki et al., 2002 (Kuriki et al., , 2003 . In our study, the weaker values of the correlations found (r ¼ 0.2-0.3) are likely due to the time shift between blood sampling (at baseline) and the fifteen 24-h records (up to 3 years after the beginning of the study).
In observational studies, the correlation found between the dietary intake of a given fatty acid and its level in a given plasma or tissue lipid fraction depends on the true value of the correlation, but also on: (1) the range of intake, (2) the precision of intake measurements and (3) the precision of the measurement of the plasma/tissue levels. Since the latter is fairly good for most fatty acids (Ma et al., 1995a) , the value of the correlation depends thus mainly on the first two factors. The range of intake of fatty fish, and thus of EPA and DHA, is very large in our study (Astorg et al., 2004) . This results in both a fairly good precision in the measurement of EPA and DHA intakes and a good correlation of EPA and DHA intakes with their plasma levels. In contrast, the range of a-linolenic acid intake has been found to be narrow in our study; 90% of both men and women consumed between 0.3 and 0.5% of energy as a-linolenic acid (Astorg et al., 2004) . This is due to the fact that rich sources (rapeseed, walnut or soybean oils) are rarely consumed in France, and that a large number of foods contribute to a-linolenic acid intake. For many of them (biscuits, pastry, margarines and so on), the food composition tables give only mean values for a-linolenic acid content, whereas, the actual values can vary widely (from 0 to 45% of fatty acids in margarines, for example), resulting in a relative lack of precision in the measurement of individual intakes, with a shift of values towards the mean. This may explain why we failed to find any correlation between the measured intakes and the plasma levels of a-linolenic acid in this study.
The fact that the dietary intakes of linoleic and of a-linolenic acids did not show any correlation with the plasma levels of their respective bioconversion products, arachidonic and long-chain n-3 PUFA, suggests that the variations of the plasma levels of these long-chain PUFA in the population sample studied are determined by their own habitual levels of intake rather than by the levels of intake of their precursors. This is likely due to the low bioconversion rate of linoleic and a-linolenic acids in humans (Burdge, 2004) . A 3-week interventional study in women has shown that in the absence of dietary arachidonic acid, even a very high level of intake of linoleic acid (20% of energy) did not increase the percentage of arachidonic in plasma cholesteryl esters (Adam et al., 2003) . The inverse correlations found in men between the intakes of long-chain n-3 PUFA and the plasma levels of some n-6 PUFA (20:2n-6, 20:3n-6 and 22:4n-6) suggests that long-chain n-3 PUFA can inhibit one or several steps of the bioconversion of linoleic acid (D-6-and D-5-desaturases, elongase) (Burdge and Calder, 2005) . Women have a higher capacity than men to metabolize linoleic and a-linolenic acid to long-chain PUFA, due to an upregulating effect of estrogens on the PUFA bioconversion pathway (Giltay et al., 2004; Burdge and Calder, 2005) . This may explain why inhibitory effects of dietary n-3 PUFA on n-6 PUFA biosynthesis from linoleic acid are not or only hardly observed in women, whereas in men, the enzymes of the desaturation-elongation pathway are less expressed, and the competition effects between the two series of PUFA may be stronger. The conversion rate of precursors to long-chain derivatives depends also on the dietary intake levels of the long-chain PUFA (Burdge, 2004; Burdge and Calder, 2005) . Thus, in vegetarian or vegan populations, having a very low or even null intake of long-chain n-3 PUFA, the plasma levels of these fatty acids were found to be low but stable with time, indicating a significant endogenous biosynthesis from a-linolenic acid (Rosell et al., 2005) . Moreover, the plasma levels of long-chain n-3 PUFA were negatively correlated with that of linoleic acid, which indicates that the conversion of a-linolenic into long-chain derivatives can be inhibited by high linoleic acid intakes. This has been confirmed in recent intervention studies, in which the intakes of high levels of linoleic acid (7-10% of calories compared to 3-4%) were found to lower the conversion of a-linolenic into EPA, in subjects maintained on diets devoid of fish and seafood (Goyens et al., 2006; Liou et al., 2007) . In our study, where the intake of long-chain n-3 PUFA was fairly high (95% of the population consumed more than 0.06% of energy or 100 mg/day) (Astorg et al., 2004) , the levels of linoleic acid and a-linolenic intakes were not found to influence the long-chain n-3 PUFA plasma levels, since the endogenous biosynthesis of these PUFA from a-linolenic was likely to be negligible compared to their direct dietary supply. At variance, linoleic acid intake influences the biosynthesis of 20:3n-9 from oleic acid negatively, a PUFA of only endogenous origin, which accumulates in blood and tissues in cases of overt EFA deficiency.
It can be concluded from this study that the percentages of linoleic acid, arachidonic acid, EPA and DHA in plasma are correlated significantly, although only weakly, with their usual dietary intake measured by repeated 24-h records. There was no such correlation with a-linolenic acid. In a population where the intakes of long-chain PUFA, and especially of long-chain n-3 PUFA, were fairly high and above the recommended levels of intakes, there was no apparent influence of the intakes of linoleic and a-linolenic acids on the plasma levels of their respective long-chain derivatives.
